Loading...

MedEquities Realty Trust

NYSE:MRT
Snowflake Description

Reasonable growth potential and fair value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
MRT
NYSE
$355M
Market Cap
  1. Home
  2. US
  3. Real Estate
Company description

MedEquities Realty Trust, Inc. (the “Company”), which was incorporated in the state of Maryland on April 23, 2014, is a self-managed and self-administered company that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The last earnings update was 7 days ago. More info.


Add to Portfolio Compare Print
MRT Share Price and Events
7 Day Returns
2.1%
NYSE:MRT
0.2%
US REITs
-3.9%
US Market
1 Year Returns
7.7%
NYSE:MRT
13%
US REITs
1.4%
US Market
MRT Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
MedEquities Realty Trust (MRT) 2.1% 4.6% 3.6% 7.7% - -
US REITs 0.2% -1.4% 3.2% 13% 8.8% 24%
US Market -3.9% -3.6% 1.8% 1.4% 35.8% 40.8%
1 Year Return vs Industry and Market
  • MRT underperformed the REITs industry which returned 13% over the past year.
  • MRT outperformed the Market in United States of America which returned 1.4% over the past year.
Price Volatility
MRT
Industry
5yr Volatility vs Market

MRT Value

 Is MedEquities Realty Trust undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of MedEquities Realty Trust to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for MedEquities Realty Trust.

NYSE:MRT Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity using Adjusted Funds From Operations
Levered Adjusted Funds From Operations Average of 5 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 8.2%
Perpetual Growth Rate 10-Year US Government Bond Rate 2.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for NYSE:MRT
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 2.7%
Equity Risk Premium S&P Global 6%
REITs Unlevered Beta Simply Wall St/ S&P Global 0.53
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.531 (1 + (1- 21%) (81.05%))
0.914
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.91
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (0.914 * 5.96%)
8.18%

Discounted Cash Flow Calculation for NYSE:MRT using 2 Stage Free Cash Flow to Equity using Adjusted Funds From Operations Model

The calculations below outline how an intrinsic value for MedEquities Realty Trust is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

MedEquities Realty Trust is a Real Estate Investment Trust (REIT), we use funds from operations (FFO) or adjusted funds from operations (AFFO) instead of levered free cash flow for REITs. This excludes depreciation and borrowing. Ideally analysts estimates of AFFO are used, where these aren't available we use FFO.

NYSE:MRT DCF 1st Stage: Next 10 year cash flow forecast
Adjusted Funds From Operations (AFFO) (USD, Millions) Source Present Value
Discounted (@ 8.18%)
2019 31.15 Analyst x3 28.79
2020 32.99 Analyst x3 28.19
2021 34.24 Est @ 3.8% 27.05
2022 35.44 Est @ 3.48% 25.88
2023 36.59 Est @ 3.26% 24.70
2024 37.72 Est @ 3.1% 23.54
2025 38.85 Est @ 2.99% 22.41
2026 39.98 Est @ 2.91% 21.32
2027 41.12 Est @ 2.86% 20.27
2028 42.28 Est @ 2.82% 19.27
Present value of next 10 years cash flows $241.40
NYSE:MRT DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= $42.28 × (1 + 2.73%) ÷ (8.18% – 2.73%)
$797.33
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $797.33 ÷ (1 + 8.18%)10
$363.29
NYSE:MRT Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $241.40 + $363.29
$604.70
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $604.70 / 31.73
$19.06
NYSE:MRT Discount to Share Price
Calculation Result
Value per share (USD) From above. $19.06
Current discount Discount to share price of $11.19
= -1 x ($11.19 - $19.06) / $19.06
41.3%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price MedEquities Realty Trust is available for.
Intrinsic value
41%
Share price is $11.19 vs Future cash flow value of $19.06
Current Discount Checks
For MedEquities Realty Trust to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • MedEquities Realty Trust's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • MedEquities Realty Trust's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for MedEquities Realty Trust's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are MedEquities Realty Trust's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NYSE:MRT PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in USD $0.06
NYSE:MRT Share Price ** NYSE (2019-05-15) in USD $11.19
United States of America REITs Industry PE Ratio Median Figure of 155 Publicly-Listed REITs Companies 32.37x
United States of America Market PE Ratio Median Figure of 3,087 Publicly-Listed Companies 17.79x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of MedEquities Realty Trust.

NYSE:MRT PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NYSE:MRT Share Price ÷ EPS (both in USD)

= 11.19 ÷ 0.06

203.37x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • MedEquities Realty Trust is overvalued based on earnings compared to the US REITs industry average.
  • MedEquities Realty Trust is overvalued based on earnings compared to the United States of America market.
Price based on expected Growth
Does MedEquities Realty Trust's expected growth come at a high price?
Raw Data
NYSE:MRT PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 203.37x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 5 Analysts
47.1%per year
United States of America REITs Industry PEG Ratio Median Figure of 141 Publicly-Listed REITs Companies 1.91x
United States of America Market PEG Ratio Median Figure of 2,113 Publicly-Listed Companies 1.52x

*Line of best fit is calculated by linear regression .

NYSE:MRT PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 203.37x ÷ 47.1%

4.32x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • MedEquities Realty Trust is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on MedEquities Realty Trust's assets?
Raw Data
NYSE:MRT PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in USD $10.85
NYSE:MRT Share Price * NYSE (2019-05-15) in USD $11.19
United States of America REITs Industry PB Ratio Median Figure of 191 Publicly-Listed REITs Companies 1.86x
United States of America Market PB Ratio Median Figure of 5,195 Publicly-Listed Companies 1.83x
NYSE:MRT PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NYSE:MRT Share Price ÷ Book Value per Share (both in USD)

= 11.19 ÷ 10.85

1.03x

* Primary Listing of MedEquities Realty Trust.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • MedEquities Realty Trust is good value based on assets compared to the US REITs industry average.
X
Value checks
We assess MedEquities Realty Trust's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the REITs industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the REITs industry average (and greater than 0)? (1 check)
  5. MedEquities Realty Trust has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

MRT Future Performance

 How is MedEquities Realty Trust expected to perform in the next 1 to 3 years based on estimates from 5 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
47.1%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is MedEquities Realty Trust expected to grow at an attractive rate?
  • MedEquities Realty Trust's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Growth vs Market Checks
  • MedEquities Realty Trust's earnings growth is expected to exceed the United States of America market average.
  • MedEquities Realty Trust's revenue growth is expected to exceed the United States of America market average.
Annual Growth Rates Comparison
Raw Data
NYSE:MRT Future Growth Rates Data Sources
Data Point Source Value (per year)
NYSE:MRT Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 5 Analysts 47.1%
NYSE:MRT Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 5 Analysts 9.9%
United States of America REITs Industry Earnings Growth Rate Market Cap Weighted Average 5.2%
United States of America REITs Industry Revenue Growth Rate Market Cap Weighted Average 4.3%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 14%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NYSE:MRT Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NYSE:MRT Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2020-12-31 70 17 3
2019-12-31 65 16 2
NYSE:MRT Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-03-31 57 23 2
2018-12-31 57 23 5
2018-09-30 60 31 12
2018-06-30 66 35 19
2018-03-31 64 40 21
2017-12-31 61 41 20
2017-09-30 59 37 13
2017-06-30 57 37 9
2017-03-31 49 35 1
2016-12-31 49 30 -3
2016-09-30 51 35 0
2016-06-30 50 31 0

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • MedEquities Realty Trust's earnings are expected to grow significantly at over 20% yearly.
  • MedEquities Realty Trust's revenue is expected to grow by 9.9% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NYSE:MRT Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below

All data from MedEquities Realty Trust Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NYSE:MRT Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2020-12-31 0.52 0.58 0.45 2.00
2019-12-31 0.49 0.54 0.42 4.00
NYSE:MRT Past Financials Data
Date (Data in USD Millions) EPS *
2019-03-31 0.06
2018-12-31 0.17
2018-09-30 0.37
2018-06-30 0.61
2018-03-31 0.66
2017-12-31 0.64
2017-09-30 0.40
2017-06-30 0.33
2017-03-31 0.03
2016-12-31 -0.18
2016-09-30 0.04
2016-06-30 0.04

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if MedEquities Realty Trust will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess MedEquities Realty Trust's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
MedEquities Realty Trust has a total score of 4/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

MRT Past Performance

  How has MedEquities Realty Trust performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare MedEquities Realty Trust's growth in the last year to its industry (REITs).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • MedEquities Realty Trust has delivered over 20% year on year earnings growth in the past 5 years.
  • MedEquities Realty Trust's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • MedEquities Realty Trust's 1-year earnings growth is negative, it can't be compared to the US REITs industry average.
Earnings and Revenue History
MedEquities Realty Trust's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from MedEquities Realty Trust Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NYSE:MRT Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 57.23 1.74 13.07
2018-12-31 57.26 5.48 13.40
2018-09-30 60.19 11.79 13.14
2018-06-30 66.27 19.25 13.90
2018-03-31 63.54 20.80 11.82
2017-12-31 61.11 20.16 11.68
2017-09-30 58.88 12.52 12.03
2017-06-30 56.96 8.58 11.42
2017-03-31 48.73 0.53 11.21
2016-12-31 49.30 -2.89 10.81
2016-09-30 50.62 0.47 10.50
2016-06-30 50.02 0.46 10.50
2016-03-31 54.35 5.39 9.52
2015-12-31 44.44 4.65 8.63
2014-12-31 8.17 0.00 4.92

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • MedEquities Realty Trust has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • MedEquities Realty Trust used its assets less efficiently than the US REITs industry average last year based on Return on Assets.
  • MedEquities Realty Trust's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess MedEquities Realty Trust's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the REITs industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
MedEquities Realty Trust has a total score of 1/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

MRT Health

 How is MedEquities Realty Trust's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up MedEquities Realty Trust's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • MedEquities Realty Trust's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • MedEquities Realty Trust's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of MedEquities Realty Trust's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is not covered by short term assets, assets are 0.1x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from MedEquities Realty Trust Company Filings, last reported 1 month ago.

NYSE:MRT Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 348.14 287.75 18.51
2018-12-31 347.36 278.14 10.58
2018-09-30 349.12 270.45 10.01
2018-06-30 356.36 264.41 7.97
2018-03-31 357.82 232.07 8.92
2017-12-31 356.75 215.52 13.89
2017-09-30 355.64 206.78 7.26
2017-06-30 355.90 163.86 8.24
2017-03-31 357.22 155.70 8.21
2016-12-31 358.26 144.00 9.51
2016-09-30 262.83 244.00 12.21
2016-06-30 265.25 244.00 7.86
2016-03-31 273.58 247.40 9.79
2015-12-31 271.25 247.40 12.47
2014-12-31 149.88 50.00 10.49
  • MedEquities Realty Trust's level of debt (82.7%) compared to net worth is high (greater than 40%).
  • Unable to establish if MedEquities Realty Trust's debt level has increased without past 5-year debt data.
  • Debt is not well covered by operating cash flow (8.1%, less than 20% of total debt).
  • Interest payments on debt are not well covered by earnings (EBIT is 1.5x annual interest expense, ideally 3x coverage).
X
Financial health checks
We assess MedEquities Realty Trust's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. MedEquities Realty Trust has a total score of 0/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

MRT Dividends

 What is MedEquities Realty Trust's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
7.51%
Current annual income from MedEquities Realty Trust dividends. Estimated to be 7.51% next year.
If you bought $2,000 of MedEquities Realty Trust shares you are expected to receive $150 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • MedEquities Realty Trust's pays a higher dividend yield than the bottom 25% of dividend payers in United States of America (1.46%).
  • MedEquities Realty Trust's dividend is above the markets top 25% of dividend payers in United States of America (3.71%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NYSE:MRT Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 5 Analyst Estimates (S&P Global) See Below
United States of America REITs Industry Average Dividend Yield Market Cap Weighted Average of 184 Stocks 3.9%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1997 Stocks 2.5%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.5%
United States of America Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NYSE:MRT Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2020-12-31 0.84 1.00
2019-12-31 0.84 1.00
NYSE:MRT Past Annualized Dividends Data
Date (Data in $) Dividend per share (annual) Avg. Yield (%)
2019-02-25 0.840 7.793
2018-11-09 0.840 9.754
2018-08-01 0.840 8.780
2018-05-08 0.840 7.821
2018-02-07 0.840 8.195
2017-11-01 0.840 7.590
2017-08-02 0.840 7.226
2017-05-03 0.840 6.907
2017-01-03 0.840 7.428
2016-11-10 0.000 0.000
2016-11-08 0.000 0.000

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Whilst dividend payments have been stable, MedEquities Realty Trust has been paying a dividend for less than 10 years.
  • MedEquities Realty Trust has only been paying a dividend for 2 years, and since then there has been no growth.
Current Payout to shareholders
What portion of MedEquities Realty Trust's earnings are paid to the shareholders as a dividend.
  • Dividends paid are covered by earnings (1.4x coverage).
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess MedEquities Realty Trust's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can MedEquities Realty Trust afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. MedEquities Realty Trust has a total score of 3/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

MRT Management

 What is the CEO of MedEquities Realty Trust's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
John McRoberts
COMPENSATION $518,267
AGE 65
TENURE AS CEO 5.1 years
CEO Bio

Mr. John W. McRoberts has been the Chief Executive Officer and President of HR Acquisition I Corporation since 1994. Mr. McRoberts has been the Chief Executive Officer and Chairman of the Board of Directors at MedEquities Realty Trust, Inc since April 23, 2014. He has been the President and Chief Executive Officer at Foresite L.L.C. since December 2000. Mr. McRoberts founded Forsite, LLC, a communications tower company that was sold to Allied Capital (NYSE: ALD) in 2005. He founded Cannongate Partners, LLC in 2000 and served as the Managing Member of Foresite Towers LLC since 1999. From October 2010 to April 2012, Mr. McRoberts served as President and subsequently as a consultant for Carter Validus Advisors, LLC. Mr. McRoberts served as Chief Executive Officer and President at Meadowbrook Healthcare, Inc. since July 2003. He served as the President and Chief Executive Officer of Capstone Capital Corporation from 1993 to 1998. He served as the Senior Vice President of AmSouth Bank from 1988 to 1993, where he was responsible for the general corporate lending activity for Birmingham and Alabama area. Mr. McRoberts co-founded Capstone Capital Corporation and Foresite Towers, LLC in 1999. He served as the Senior Officer of AmSouth Bank from 1977 to 1993. Mr. McRoberts has been a Director of Tectonic Network Inc. since 2000. He serves as the Director of ROI Corporation and ForeSite Towers, LLC. Mr. McRoberts has been a Director of HR Acquisition I Corporation since 1994. He served as the Director of Medcenterdirect.com Inc. since December 1999 and Net Tech International Inc. since 1996. He served as a Director of Results Oriented Integration Corporation since 1996 until its reverse merger in August 2000. He is a graduate and holds a Masters in Finance from University of Alabama.

CEO Compensation
  • John's compensation has been consistent with company performance over the past year.
  • John's remuneration is lower than average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the MedEquities Realty Trust management team in years:

4.8
Average Tenure
48
Average Age
  • The tenure for the MedEquities Realty Trust management team is about average.
Management Team

John McRoberts

TITLE
Chairman & CEO
COMPENSATION
$518K
AGE
65
TENURE
5.1 yrs

Bill Harlan

TITLE
President
COMPENSATION
$512K
AGE
66
TENURE
5.1 yrs

Jeff Walraven

TITLE
Executive VP
COMPENSATION
$366K
AGE
48
TENURE
5.1 yrs

David Travis

TITLE
Senior VP & Chief Accounting Officer
AGE
43
TENURE
4.8 yrs

Tripp Sullivan

TITLE
Investor Relations

Forrest Gardner

TITLE
Senior Vice President of Asset & Investment Management
AGE
45
TENURE
4.8 yrs

Michael Hammill

TITLE
Senior Vice President of Finance & Capital Markets
AGE
37
TENURE
4 yrs

Steve Graham

TITLE
Senior VP and Director of Post Acute Acquisition & Development
AGE
57
TENURE
3.9 yrs
Board of Directors Tenure

Average tenure and age of the MedEquities Realty Trust board of directors in years:

4.8
Average Tenure
65.5
Average Age
  • The tenure for the MedEquities Realty Trust board of directors is about average.
Board of Directors

Bill Harlan

TITLE
President
COMPENSATION
$512K
AGE
66
TENURE
5.1 yrs

Randy Churchey

TITLE
Lead Independent Director
COMPENSATION
$148K
AGE
57

John McRoberts

TITLE
Chairman & CEO
COMPENSATION
$518K
AGE
65
TENURE
5.1 yrs

John Foy

TITLE
Independent Director
COMPENSATION
$150K
AGE
74
TENURE
4.8 yrs

Stephen Guillard

TITLE
Independent Director
COMPENSATION
$133K
AGE
68
TENURE
3.8 yrs

Steve Geringer

TITLE
Independent Director
COMPENSATION
$133K
AGE
72
TENURE
3.8 yrs

Elliott Mandelbaum

TITLE
Independent Director
COMPENSATION
$154K
AGE
33
TENURE
4.8 yrs

Todd Mansfield

TITLE
Independent Director
COMPENSATION
$126K
AGE
60
TENURE
1.3 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
29. Jan 19 Sell BlueMountain Capital Management LLC Company 25. Jan 19 28. Jan 19 -134,126 $11.20 $-1,492,461
25. Jan 19 Sell BlueMountain Capital Management LLC Company 23. Jan 19 24. Jan 19 -362,699 $11.03 $-3,969,220
23. Jan 19 Sell BlueMountain Capital Management LLC Company 18. Jan 19 22. Jan 19 -139,235 $10.95 $-1,513,293
18. Jan 19 Sell BlueMountain Capital Management LLC Company 16. Jan 19 16. Jan 19 -1,678 $10.94 $-18,357
18. Jan 19 Sell BlueMountain Capital Management LLC Company 16. Jan 19 17. Jan 19 -302,815 $10.94 $-3,284,709
16. Jan 19 Sell BlueMountain Capital Management LLC Company 14. Jan 19 15. Jan 19 -208,954 $10.72 $-2,225,044
15. Jan 19 Sell BlueMountain Capital Management LLC Company 14. Jan 19 14. Jan 19 -60,000 $10.57 $-631,850
14. Jan 19 Sell BlueMountain Capital Management LLC Company 10. Jan 19 11. Jan 19 -255,000 $10.62 $-2,692,150
10. Dec 18 Sell BlueMountain Capital Management LLC Company 06. Dec 18 06. Dec 18 -4,617 $6.67 $-30,795
06. Dec 18 Sell BlueMountain Capital Management LLC Company 03. Dec 18 04. Dec 18 -13,346 $6.95 $-91,954
03. Dec 18 Sell BlueMountain Capital Management LLC Company 29. Nov 18 30. Nov 18 -29,051 $7.10 $-203,071
29. Nov 18 Sell BlueMountain Capital Management LLC Company 27. Nov 18 28. Nov 18 -21,601 $7.10 $-152,185
27. Nov 18 Sell BlueMountain Capital Management LLC Company 23. Nov 18 26. Nov 18 -15,607 $7.17 $-111,690
21. Nov 18 Sell BlueMountain Capital Management LLC Company 19. Nov 18 21. Nov 18 -8,714 $7.50 $-62,877
19. Nov 18 Sell BlueMountain Capital Management LLC Company 15. Nov 18 16. Nov 18 -28,027 $7.55 $-210,854
15. Nov 18 Sell BlueMountain Capital Management LLC Company 13. Nov 18 14. Nov 18 -57,234 $8.30 $-446,923
13. Nov 18 Sell BlueMountain Capital Management LLC Company 09. Nov 18 12. Nov 18 -37,530 $8.85 $-327,869
09. Nov 18 Sell BlueMountain Capital Management LLC Company 07. Nov 18 08. Nov 18 -35,783 $8.66 $-307,560
07. Nov 18 Sell BlueMountain Capital Management LLC Company 05. Nov 18 06. Nov 18 -25,765 $8.70 $-220,999
05. Nov 18 Sell BlueMountain Capital Management LLC Company 01. Nov 18 02. Nov 18 -35,635 $8.45 $-298,371
01. Nov 18 Sell BlueMountain Capital Management LLC Company 30. Oct 18 31. Oct 18 -27,998 $8.50 $-235,483
30. Oct 18 Sell BlueMountain Capital Management LLC Company 26. Oct 18 29. Oct 18 -11,695 $8.45 $-98,073
26. Oct 18 Sell Goldman Sachs Group, Investment Banking and Securities Investments Company 24. Aug 18 23. Oct 18 -548,621 $10.76 $-5,903,162
26. Oct 18 Buy Goldman Sachs Group, Investment Banking and Securities Investments Company 24. Aug 18 23. Oct 18 515,780 $10.75 $5,544,635
26. Oct 18 Sell BlueMountain Capital Management LLC Company 24. Oct 18 25. Oct 18 -25,546 $8.51 $-215,946
24. Oct 18 Sell BlueMountain Capital Management LLC Company 22. Oct 18 23. Oct 18 -14,196 $8.70 $-120,710
22. Oct 18 Sell BlueMountain Capital Management LLC Company 18. Oct 18 19. Oct 18 -11,837 $8.75 $-102,524
18. Oct 18 Sell BlueMountain Capital Management LLC Company 16. Oct 18 17. Oct 18 -23,200 $8.95 $-205,090
16. Oct 18 Sell BlueMountain Capital Management LLC Company 12. Oct 18 15. Oct 18 -21,289 $8.88 $-187,246
12. Oct 18 Sell BlueMountain Capital Management LLC Company 09. Oct 18 11. Oct 18 -31,239 $9.29 $-286,757
09. Oct 18 Sell BlueMountain Capital Management LLC Company 05. Oct 18 08. Oct 18 -18,052 $9.39 $-166,160
31. May 18 Sell BlueMountain Capital Management LLC Company 29. May 18 29. May 18 -9,948 $10.36 $-102,905
29. May 18 Sell BlueMountain Capital Management LLC Company 24. May 18 25. May 18 -23,421 $10.40 $-242,138
24. May 18 Sell BlueMountain Capital Management LLC Company 22. May 18 23. May 18 -28,887 $10.30 $-296,036
22. May 18 Sell BlueMountain Capital Management LLC Company 17. May 18 21. May 18 -57,666 $10.41 $-595,778
X
Management checks
We assess MedEquities Realty Trust's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. MedEquities Realty Trust has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

MRT News

Simply Wall St News

Is There Now An Opportunity In MedEquities Realty Trust, Inc. (NYSE:MRT)?

led the NYSE gainers with a relatively large price hike in the past couple of weeks. … With many analysts covering the stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price? … Let’s examine MedEquities Realty Trust’s valuation and outlook in more detail to determine if there’s still a bargain opportunity

Simply Wall St -

Did MedEquities Realty Trust Inc (NYSE:MRT) Insiders Sell Their Own Shares?

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. … MedEquities Realty Trust's insiders have divested from. … It is widely considered that insider selling stock in their own companies is potentially a bearish signal

Simply Wall St -

You Should Buy MedEquities Realty Trust Inc (NYSE:MRT) Because Of These Reasons

MedEquities Realty Trust Inc (NYSE:MRT) is a company with exceptional fundamental characteristics. … Upon building up an investment case for a stock, we should look at various aspects. … In the case of MRT, it.

Simply Wall St -

3 Days Left To MedEquities Realty Trust Inc (NYSE:MRT)’s Ex-Dividend Date, Is It Worth Buying?

Check out our latest analysis for MedEquities Realty Trust 5 checks you should do on a dividend stock Whenever I am looking at a potential dividend stock investment, I always check these five metrics: Is their annual yield among the top 25% of dividend payers? … NYSE:MRT Historical Dividend Yield May 17th 18 How does MedEquities Realty Trust fare? … Unfortunately, it is really too early to view MedEquities Realty Trust as a dividend investment.

Simply Wall St -

Cheap Real Estate Stocks To Watch Out For In May

MedEquities Realty Trust and Braemar Hotels & Resorts are real estate companies that are currently trading below what they’re actually worth. … (NYSE:MRT) MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. … NYSE:MRT PE PEG Gauge May 7th 18 Braemar Hotels & Resorts, Inc.

Simply Wall St -

Should Income Investors Buy MedEquities Realty Trust Inc (MRT) Before Its Ex-Dividend?

See our latest analysis for MRT Here's how I find good dividend stocks When assessing a stock as a potential addition to my dividend Portfolio, I look at these five areas: Is it paying an annual yield above 75% of dividend payers? … NYSE:MRT Historical Dividend Yield Nov 11th 17 How well does MedEquities Realty Trust fit our criteria? … After digging a little deeper into MRT's yield, it's easy to see why you should be cautious investing in the company just for the dividend.

Simply Wall St -

MRT Company Info

Description

MedEquities Realty Trust, Inc. (the “Company”), which was incorporated in the state of Maryland on April 23, 2014, is a self-managed and self-administered company that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. As of March 31, 2019, the Company had investments of $589.4 million, net in 34 real estate properties and six healthcare-related real estate debt investments. The Company owns 100% of all of its properties and investments, other than Baylor Scott & White Medical Center - Lakeway (“Lakeway Hospital”), in which the Company owns a 51% interest through a consolidated partnership (the “Lakeway Partnership”). All of the Company’s assets are held by, and its operations conducted through, its operating partnership, MedEquities Realty Operating Partnership, LP, which is a 100% owned subsidiary of the Company. The Company has elected to be taxed as a real estate investment trust (“REIT”) for U.S. federal income tax purposes.

Details
Name: MedEquities Realty Trust, Inc.
MRT
Exchange: NYSE
Founded: 2014
$355,023,485
31,726,853
Website: http://www.medequities.com
Address: MedEquities Realty Trust, Inc.
3100 West End Avenue,
Suite 1000,
Nashville,
Tennessee, 37203,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NYSE MRT Common Shares New York Stock Exchange US USD 29. Sep 2016
Number of employees
Current staff
Staff numbers
11
MedEquities Realty Trust employees.
Industry
Health Care REITs
Real Estate
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/05/16 02:47
End of day share price update: 2019/05/15 00:00
Last estimates confirmation: 2019/05/02
Last earnings filing: 2019/05/09
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.